Document Detail


Pregnancy and breastfeeding in patients with Crohn's disease.
MedLine Citation:
PMID:  18239407     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Crohn's disease commonly affects women of childbearing age. Available data on Crohn's disease and pregnancy show that women with Crohn's disease can expect to conceive successfully, carry to term and deliver a healthy baby. Control of disease activity before conception and during pregnancy is critical, to optimize both maternal and fetal health. Generally speaking, pharmacological therapy for Crohn's disease during pregnancy is similar to pharmacological therapy for nonpregnant patients. Patients maintained in remission by way of pharmacological therapy should continue it throughout their pregnancy. Sulfasalazine, mesalazine and corticosteroids are safe, azathioprine and 6-mercaptopurine are reasonably safe with few discordant data, infliximab seems safe as well, whereas methotrexate is contraindicated during pregnancy. During breastfeeding, mesalazine and prednisone are considered safe, azathioprine/6-mercaptopurine, budesonide and infliximab probably safe and methotrexate is contraindicated.
Authors:
Christian Mottet; Pascal Juillerat; Valérie Pittet; Jean-Jacques Gonvers; Florian Froehlich; John-Paul Vader; Pierre Michetti; Christian Felley
Related Documents :
11684827 - Ischemic colitis during pregnancy and contraceptive medication.
10855857 - Hemangiosarcoma of the breast followed by term pregnancy.
9133937 - Behçet's disease and pregnancy relationship study.
9526727 - Consanguineous marriage in an urban area of saudi arabia: rates and adverse health effe...
11675347 - Slow, programmed maturation of the immunoglobulin hcdr3 repertoire during the third tri...
10656857 - Regression analysis of time trends in perinatal mortality in germany 1980-1993.
Publication Detail:
Type:  Journal Article; Review     Date:  2008-02-07
Journal Detail:
Title:  Digestion     Volume:  76     ISSN:  1421-9867     ISO Abbreviation:  Digestion     Publication Date:  2007  
Date Detail:
Created Date:  2008-02-01     Completed Date:  2008-03-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0150472     Medline TA:  Digestion     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  149-60     Citation Subset:  IM    
Copyright Information:
Copyright 2008 S. Karger AG, Basel.
Affiliation:
Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. christian.mottet@chuv.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Breast Feeding*
Crohn Disease* / drug therapy
Drug Therapy, Combination
Female
Glucocorticoids / therapeutic use
Humans
Immunologic Factors / therapeutic use
Mesalamine
Pregnancy
Pregnancy Complications* / drug therapy
Pregnancy Outcome
Safety
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 0/Anti-Inflammatory Agents, Non-Steroidal; 0/Glucocorticoids; 0/Immunologic Factors; 89-57-6/Mesalamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extraintestinal manifestations of Crohn's disease.
Next Document:  Drug safety in Crohn's disease therapy.